Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
The Bronchial Tree01:23

The Bronchial Tree

The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global pMDI Use and the Potential Impact of European PFAS Legislation on Access to These Essential Inhaled Medications.

Pulmonary therapy·2026
Same author

Response.

Chest·2026
Same author

Exhaled breath condensate based breath analyser: Real-time thermofluidic standardisation of hydrogen peroxide for longitudinal COPD monitoring: a pilot investigation.

Respiratory medicine·2026
Same author

Carbon dioxide equivalent emissions and cost impact of non-clinically driven inhaler initiation or switch for COPD.

Current medical research and opinion·2026
Same author

Key factors for implementing inhaler regimen switches in respiratory diseases: international expert consensus generated using a modified nominal group technique (NGT).

NPJ primary care respiratory medicine·2026
Same author

Interpreting respiratory oscillometry in adults with asthma or COPD: findings of an international Delphi study.

ERJ open research·2025
Same journal

Residual AHI Measurement from PAP Devices Versus Home Polygraphy: A Method Comparison Study Using Real World Data.

Respiration; international review of thoracic diseases·2026
Same journal

Unveiling Sex Differences in Severe Acute COPD Exacerbations requiring ICU admission: Evidence from a French Cohort.

Respiration; international review of thoracic diseases·2026
Same journal

Intrapleural Fibrinolytics use in Children with Pleural Empyema: Safe and Effective.

Respiration; international review of thoracic diseases·2026
Same journal

Learning Curve for Transbronchial Lung Cryobiopsy in Interstitial Lung Disease Diagnosis: A Multicenter Experience.

Respiration; international review of thoracic diseases·2026
Same journal

Follow-Up Care After Adult Lung Transplantation: Summary of an Evidence-Based Clinical Practice Guideline for German-Speaking Countries.

Respiration; international review of thoracic diseases·2026
Same journal

Real-world Sotatercept Eligibility: Analysis from the FOCUS-PAH Registry.

Respiration; international review of thoracic diseases·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Treating the small airways.

Omar S Usmani1

  • 1Airway Disease Section, National Heart and Lung Institute, Imperial College London, and Royal Brompton Hospital, London, UK. o.usmani@imperial.ac.uk

Respiration; International Review of Thoracic Diseases
|November 17, 2012
PubMed
Summary
This summary is machine-generated.

This study reviews treatments for the small-airway region in lung diseases. It examines inhaled therapies targeting the lung periphery for asthma and chronic obstructive pulmonary disease patients.

More Related Videos

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Related Experiment Videos

Last Updated: May 16, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Pharmacology

Background:

  • The small-airway region is crucial in lung function and disease.
  • Current treatments often focus on central airways, potentially missing peripheral targets.
  • Asthma and chronic obstructive pulmonary disease (COPD) involve small airway inflammation and obstruction.

Purpose of the Study:

  • To evaluate therapeutic approaches targeting the small-airway region.
  • To explore the clinical implications of peripheral inhaled therapy.
  • To provide insights for managing asthma and COPD.

Main Methods:

  • Literature review of current treatment strategies.
  • Analysis of inhaled therapies focusing on peripheral lung deposition.
  • Evaluation of clinical trial data and outcomes.

Main Results:

  • Peripheral targeting may improve treatment efficacy in specific patient subgroups.
  • Inhaled therapies need optimization for small airway delivery.
  • Understanding regional drug deposition is key.

Conclusions:

  • Targeting the small airways offers a promising strategy for asthma and COPD.
  • Further research is needed to optimize inhaled therapies for peripheral delivery.
  • Personalized approaches considering regional lung disease are essential.